Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Biomed Imaging ; 2022: 8705531, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35528224

RESUMO

Breast MRI possesses high sensitivity for detecting breast cancer among the current clinical modalities and is an indispensable imaging practice. Breast MRI comprises diffusion-weighted imaging, ultrafast, and T2 weighted and T1 weighted CE (contrast-enhanced) imaging that may be utilized for improving the characterization of the lesions. This multimodal evaluation of breast lesions enables outstanding discrimination between the malignant and benign and malignant lesions. The expanding indications of breast MRI confirm the far superiority of MRI in preoperative staging, especially in the estimation of tumour size and identifying tumour foci in the contralateral and ipsilateral breast. Recent studies depicted that experts can meritoriously utilize this tool for improving breast cancer surgery despite their existence of no significant long term outcomes. For managing the, directly and indirectly, associated screening cost, abbreviated protocols are found to be more beneficial. Further, in some of the patients who were treated with neoadjuvant chemotherapy, breast MRI is utilized for documenting response. It is therefore essential to realise that oncological screening must be easily available, cost-effective, and time-consuming. Earlier detection of this short sequence protocol leads to prior and early breast cancer disease in high risky female populations like women with dense breasts, prehistoric evidence, etc. This proper utilization of AP reduces unnecessary mastectomies. Hence, this review focused on the explorative information for strongly suggesting the benefits of AP breast MRI compared to full diagnostic protocol MRI.

2.
Materials (Basel) ; 15(8)2022 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-35454597

RESUMO

The aim of this study is to compare the optical responses of external beam therapy 3 (EBT3) films exposed to X-rays and solar ultraviolet rays (SUV-rays), as a dose control technique in the clinical sector for various radiation types, energies, and absorbed doses up to 4 Gy. In this study, EBT3 films with three different expiry dates were prepared and cut into pieces of size 2 by 2 cm2. The first group was exposed to 90 kVp X-rays, while the second group was exposed to the SUV-rays at noon. The analysis was performed using a visible Jaz spectrometer and an EPSON Perfection V370 Photo scanner to obtain the absorbance, the net reflective optical density (ROD) and the red-green-blue (RGB) values of the samples. The results have shown that spectroscopic measurements of the exposed expired EBT3 films with these radiation sources are able to produce primary peaks and secondary peaks at λ = 641.74 nm and λ = 585.98 nm for X-rays, and at λ = 637.93 nm and λ = 584.45 nm for SUV-rays, respectively. According to these findings, compared to 2021 films that expired shortly before the trial start date; 2018 films responded better to the absorbed dose than 2016 films when exposed to both X-ray and SUV-rays. In terms of energy dependence, the expired EBT3 2018 had the largest net ROD value. Using L*a*b* indices extracted from the RGB data, and despite that EBT3 films have expiry dates according to the manufacturer; all the films exhibited a substantial colour change, indicating that these films are still usable for clinical and research purposes.

3.
J Clin Med ; 7(4)2018 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-29642517

RESUMO

Data evaluating the effect of asymptomatic effects of radiation on thyroid hormone panels and ultrasonographic abnormalities among radiology technologists are scarce. This study aimed to determine the asymptomatic effect of radiation in a total of 39 male and 11 female exposed radiology technologists working in radiology departments, and a total of 34 male and 16 female age-matched controls working in other departments in the same hospital. The level of triiodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) were evaluated using Enzyme Linked Immunosorbent Assay (ELISA). Thyroid ultrasonographic evaluation outcomes were given as normal or abnormal. There was significant interaction between exposure and gender in the mean TSH and T4 but not T3. The mean TSH for exposed men was significantly higher than that among non-exposed men (2.28 mIU/L vs. 1.59 mIU/L; p-value = 0.003). The mean TSH was not significantly different between exposed and non-exposed women. The mean T4 for exposed men was significantly higher when compared with non-exposed men (11.1 pmol/L vs. 10.05 pmol/L; p-value = 0.005). In the non-exposed group, 93.8% of women and 94.1% of men had T4 values lower than established normal reference range, while in the exposed group, 90.9% of women and 74.4% of men had low values of T4. There was no significant difference in mean T3 between exposed and non-exposed groups for men and women. Furthermore, there were no significant differences in the thyroid gland ultrasonographic findings between exposed and non-exposed groups. Occupational radiation exposure is associated with increased means of TSH and T3, especially among men.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...